
EssilorLuxottica (EL) | Financial Analysis & Statements
EssilorLuxottica S.A. | Large-cap | Healthcare
EssilorLuxottica S.A. | Large-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
26.5B
Gross Profit
16.8B
63.40%
Operating Income
3.4B
13.00%
Net Income
2.5B
9.40%
EPS (Diluted)
€5.13
Balance Sheet Metrics
Total Assets
64.3B
Total Liabilities
23.3B
Shareholders Equity
41.0B
Debt to Equity
0.57
Cash Flow Metrics
Operating Cash Flow
2.2B
Free Cash Flow
3.4B
Revenue & Profitability Trend
EssilorLuxottica Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 26.5B | 25.4B | 24.5B | 19.8B | 14.4B |
Cost of Goods Sold | 9.7B | 9.3B | 8.9B | 7.6B | 6.2B |
Gross Profit | 16.8B | 16.0B | 15.6B | 12.2B | 8.2B |
Operating Expenses | 13.4B | 12.9B | 12.5B | 10.0B | 7.7B |
Operating Income | 3.4B | 3.2B | 3.2B | 2.2B | 452.0M |
Pre-tax Income | 3.3B | 3.0B | 3.0B | 2.2B | 313.0M |
Income Tax | 800.0M | 609.0M | 751.0M | 582.0M | 164.0M |
Net Income | 2.5B | 2.4B | 2.3B | 1.6B | 149.0M |
EPS (Diluted) | €5.13 | €5.08 | €4.83 | €3.18 | €0.19 |
Income Statement Trend
EssilorLuxottica Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 10.0B | 9.7B | 8.6B | 9.3B | 13.7B |
Non-Current Assets | 54.2B | 50.8B | 51.9B | 50.1B | 38.6B |
Total Assets | 64.3B | 60.5B | 60.6B | 59.4B | 52.3B |
Liabilities | |||||
Current Liabilities | 10.6B | 8.4B | 7.9B | 8.7B | 6.2B |
Non-Current Liabilities | 12.7B | 13.2B | 14.5B | 14.9B | 13.4B |
Total Liabilities | 23.3B | 21.6B | 22.4B | 23.5B | 19.5B |
Equity | |||||
Total Shareholders Equity | 41.0B | 38.9B | 38.1B | 35.9B | 32.8B |
Balance Sheet Composition
EssilorLuxottica Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.5B | 2.4B | 2.3B | 1.6B | 149.0M |
Operating Cash Flow | 2.2B | 2.3B | 2.2B | 2.0B | 1.5B |
Investing Activities | |||||
Capital Expenditures | -1.5B | -1.5B | -1.6B | -1.0B | -642.0M |
Investing Cash Flow | -3.3B | -1.6B | -2.5B | -8.1B | -767.0M |
Financing Activities | |||||
Dividends Paid | -1.2B | -487.0M | -454.0M | -138.0M | -503.0M |
Financing Cash Flow | -615.0M | -1.4B | -3.9B | -1.2B | 1.8B |
Free Cash Flow | 3.4B | 3.3B | 3.2B | 3.5B | 2.3B |
Cash Flow Trend
EssilorLuxottica Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
46.92
Forward P/E
31.38
Price to Book
2.72
Price to Sales
4.19
PEG Ratio
31.38
Profitability Ratios
Profit Margin
8.90%
Operating Margin
11.43%
Return on Equity
6.24%
Return on Assets
3.49%
Financial Health
Current Ratio
0.95
Debt to Equity
32.23
Beta
0.77
Per Share Data
EPS (TTM)
€5.13
Book Value per Share
€88.41
Revenue per Share
€58.40
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
el | 111.0B | 46.92 | 2.72 | 6.24% | 8.90% | 32.23 |
Dassault Systèmes SE | 40.5B | 34.70 | 4.53 | 13.61% | 18.69% | 27.37 |
Coty | 3.6B | 39.88 | 1.04 | -9.03% | -6.60% | 104.32 |
Galeo Concept | 127.7M | 9.33 | 0.62 | 11.04% | 5.14% | 1.40 |
Jacques Bogart S.A | 73.1M | 12.88 | 0.89 | 0.78% | -0.15% | 258.73 |
La Savonnerie de | 7.1M | 14.21 | - | 16.37% | 67.04% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.